Local Prescribing Information
On this page you will find local prescribing information including updates to the local formulary.
The local formulary is available online – Cambridgeshire and Peterborough netFormulary It is also available as an app from both the apple store and galaxy play. Search for netFormulary and once the app has downloaded select Cambridgeshire and Peterborough.
Cambridgeshire and Peterborough has guidance on bulk prescribing for care homes. It includes some specific advice and resources for community pharmacies
DOAC Notification for CPs Dec 2024
Switching Fostair MDI to Bibecfo MDI for Adult Asthmatic Patients – September 2024
The Cambridgeshire and Peterborough system-wide Formulary has recently been updated with the following recommendations:
- Bibecfo® pressurised metered dose inhaler (pMDI) is recommended as first line choice for asthma in adults, where a patient is unable to be switched to a dry powder inhaler (DPI)
- Fostair NEXThaler® DPI (dry powder inhaler) remains the first line choice dry powder inhaler for asthma in adults.
- Fostair® pMDI has been reclassified to black switch (non-formulary) i.e., not recommended for prescribing in primary or secondary care.
The Asthma Management in adults flowchart has been updated to include these new recommendations. Please refer to NetFormulary for more information.
Practices will be reviewing their prescribing of Fostair MDI, and the switch process will be facilitated directly by Eclipse Live via their Boomerang system software tool. Boomerang is an interface within the Eclipse platform (that facilitates medication optimisation switches. The Eclipse Team will contact patients and provide all the necessary information for the new inhaler via text message. The switch is an opt out switch therefore if patients do not respond within 7 days they may be switched automatically. Patients will have access to a helpline telephone number if they wish to discuss further with the Eclipse Team.
Spacer devices for pMDIs – prescribing support document May 2024
Prescribing Update Nov 2022 – Diabetes Monitoring Technology
Update from the Valproate Safety and Implementation Group 08 February 2024
The patient materials have been updated sent out to all pharmacies.
Additional hard copies can be ordered by contacting Sanofi Medical Information on 0800 035 2525 or by emailing uk-medicalinformation@sanofi.com. They can also be downloaded from the eMC website by searching for epilim or depakote.
